Natural Health Trends Corp. Launches Lexxus India; Subsidiary Enters One of the World's Largest Markets as Product Distribution Grows to 25 Countries

DALLAS--(BUSINESS WIRE)--Aug. 13, 2002--Natural Health Trends Corp. (OTCBB:NHTC) announced it has launched its newest subsidiary, Lexxus India. The Company, which has been expanding globally over the past year and reported revenues of approximately $6,154,000 for the three months ended March 31, 2002 compared to approximately $3,186,000 for the same period last year, is optimistic that the new India-based subsidiary will be its strongest launch to date.

The new Indian corporate office is located in Hyderabad in the state of Andhra Pradesh in southern India. Hyderabad is a city in excess of seven million people and is the center of the Indian computer industry.

Lexxus India, a subsidiary of Natural Health Trends Corp., is marketing and distributing the Company's popular quality of life Alura(TM) product, among others. Alura(TM) is a patented intimacy creme that helps promote clitoral sensitivity and helps improve the opportunity for women to achieve greater sexual satisfaction.

"We have been greatly encouraged by the strong performance realized with past openings and are confident that the Alura(TM) product will prove to be very successful here as well," said Ajay Jaswal, Managing Director for Lexxus India.

"It has been a very exciting year for Natural Health Trends as we have entered several new markets this year. To enter such a grand market is extremely rewarding, as India is the twenty-fifth country to join our Lexxus family," said Mark Woodburn, President of Natural Health Trends Corp. "Being one of the largest markets in the world, India is a key component in our record-breaking, global-expansion program," he concluded.

About Natural Health Trends Corp.

Natural Health Trends Corporation is a holding company for two operating subsidiaries,, Inc., which sells nutritional supplements and vitamins and Lexxus International, Inc. Lexxus, started in January 2001, markets and sells the revolutionary new product, Alura(TM). Alura, developed by a leading gynecologist, is a quality-of-life product that contains ingredients to help promote clitoral sensitivity and to help improve the opportunity for women to achieve greater sexual satisfaction. More information may be obtained at or at

When used in Form 10-QSB and in future filings by the Company with the Securities and Exchange Commission, the words "will likely result," "the Company expects," "will continue," "is anticipated," "estimated," "projected," "outlook" or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. The Company wishes to caution readers not to place undue reliance on such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The Company has no obligation to publicly release the results of any revisions, which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.